Recent Securities Litigations

Jaguar Health Inc. Common Stock (NASDAQ: JAGX)

Company Name:Jaguar Health Inc. Common Stock
Stock Symbol:NASDAQ: JAGX
Class Period Start:06/30/2017
Class Period End (inclusive):07/31/2017

According to the Complaint, it is alleged Defendants have violated Sections of the Exchange Act by causing a materially incomplete and misleading joint proxy statement/prospectus/information statement (the "Proxy") to be filed with the SEC and disseminated to Jaguar shareholders. The Proxy recommends that Jaguar shareholders vote in favor of a Proposed Merger whereby Jaguar, in an all-stock transaction, will acquire Napo, with Jaguar continuing as the surviving entity (the "Proposed Merger").